Clinical trial
Antileukotriene Therapy for COPD Exacerbations
NCT00493974 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Antileukotriene Therapy for COPD Exacerbations
- Lead sponsor
- University of Minnesota
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- March 31, 2007
- Completion date
- December 31, 2008
- Enrollment
- 119 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.